| Ident. | Authors (with country if any) | Title |
|---|
| 000092 (2020) |
H S Young [Royaume-Uni] ; I D Kamaly-Asl [Royaume-Uni] ; P M Laws [Royaume-Uni] ; P. Pemberton [Royaume-Uni] ; C E M. Griffiths [Royaume-Uni] | Genetic interaction between placental growth factor and vascular endothelial growth factor A in psoriasis. |
| 000097 (2020) |
Dimitrios Stefanopoulos [Grèce] ; Narjes Nasiri-Ansari [Grèce] ; Ismene Dontas [Grèce] ; Andromachi Vryonidou [Grèce] ; Antonis Galanos [Grèce] ; Loukia Psaridi [Grèce] ; Ioannis G. Fatouros [Grèce] ; George Mastorakos [Grèce] ; Athanasios G. Papavassiliou [Grèce] ; Eva Kassi [Grèce] ; Symeon Tournis [Grèce] | Fibroblast Growth Factor 23 (FGF23) and Klotho Protein in Beta-Thalassemia. |
| 000208 (2019) |
A R J V. Vossen [Pays-Bas] ; C B Ardon [Pays-Bas] ; H H Van Der Zee [Pays-Bas] ; E. Lubberts [Pays-Bas] ; E P Prens [Pays-Bas] | The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study. |
| 000215 (2019) |
Mai A. Zaafan [Égypte] ; Amr M. Abdelhamid [Égypte] ; Sherine M. Ibrahim [Égypte] | The Protective Effect of Korean Red Ginseng Against Rotenone-Induced Parkinson's Disease in Rat Model: Modulation of Nuclear Factor-κβ and Caspase-3. |
| 000276 (2019) |
Seema A. Patil [États-Unis] ; Mark H. Flasar [États-Unis] ; Jay Lin [États-Unis] ; Melissa Lingohr-Smith [États-Unis] ; Martha Skup [États-Unis] ; Song Wang [États-Unis] ; Jingdong Chao [États-Unis] ; Raymond K. Cross [États-Unis] | Reduced Imaging Radiation Exposure and Costs Associated with Anti-Tumor Necrosis Factor Therapy in Crohn's Disease. |
| 000392 (2019) |
Juan-Juan Zhu [République populaire de Chine] ; Zhi-Ze Ye [République populaire de Chine] ; Chang-Sheng Li [République populaire de Chine] ; Saima Kausar [Pakistan] ; Muhammad Nadeem Abbas [Pakistan] ; Guang-Heng Xiang [République populaire de Chine] ; Xing-Yi Qian [République populaire de Chine] ; Li-Shang Dai [République populaire de Chine] | Identification and molecular characterization of a novel anti-lipopolysaccharide factor (ALF) from red swamp crayfish, Procambarus clarkii. |
| 000444 (2019) |
Marco Bertucci Zoccali [États-Unis] ; Neil H. Hyman [États-Unis] ; Kinga B. Skowron [États-Unis] ; Michele Rubin [États-Unis] ; Lisa M. Cannon [États-Unis] ; Roger D. Hurst [États-Unis] ; Konstantin Umanskiy [États-Unis] ; David T. Rubin [États-Unis] ; Benjamin D. Shogan [États-Unis] | Exposure to Anti-tumor Necrosis Factor Medications Increases the Incidence of Pouchitis After Restorative Proctocolectomy in Patients With Ulcerative Colitis. |
| 000484 (2019) |
Anbok Lee [Corée du Sud] ; Sunmi Jo [Corée du Sud] ; Changhu Lee [Corée du Sud] ; Hyun-Hee Shin [Corée du Sud] ; Tae Hyun Kim [Corée du Sud] ; Ki Jung Ahn [Corée du Sud] ; Sung-Kwang Park [Corée du Sud] ; Heunglae Cho [Corée du Sud] ; Hye-Kyoung Yoon [Corée du Sud] ; Woo Gyeong Kim [Corée du Sud] ; Jiyoung Park [Corée du Sud] ; Yunseon Choi [Corée du Sud] | Diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy. |
| 000513 (2019) |
Alexandre Virone [France] ; Jean-Philippe Bastard [France] ; Soraya Fellahi [France] ; Jacqueline Capeau [France] ; Stéphanie Rouanet [France] ; Jean Sibilia [France] ; Philippe Ravaud [France] ; Francis Berenbaum [France] ; Jacques-Eric Gottenberg [France] ; Jérémie Sellam [France] | Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis. |
| 000516 (2019) |
Iman Hamed Bassyouni [Égypte] ; Wafaa Hob Sharkawy Mohammed [Égypte] ; Fatma M. Taha [Égypte] ; Rasha M. El Refai [Égypte] | Clinical significance of CCN2/connective tissue growth factor in Behçet's disease patients. |
| 000626 (2018) |
Tamirys Simão Pimenta [Brésil] ; Natalie Ferreira Chaves [Brésil] ; Ana Paula Drummond Rodrigues [Brésil] ; Cristovam Wanderley Picanço Diniz [Brésil] ; Renato Augusto Damatta [Brésil] ; José Antônio Picanço Diniz Junior [Brésil] | Granulocyte macrophage colony-stimulating factor alone reduces Toxoplasma gondii replication in microglial culture by superoxide and nitric oxide, without IFN-γ production: a preliminary report. |
| 000628 (2018) |
Ioannis Papalopoulos [Grèce] ; Antonis Fanouriakis [Grèce] ; Nikolaos Kougkas [Grèce] ; Irini Flouri [Grèce] ; George Sourvinos [Grèce] ; George Bertsias [Grèce] ; Argyro Repa [Grèce] ; Nestor Avgoustidis [Grèce] ; Prodromos Sidiropoulos [Grèce] | Liver safety of non-tumour necrosis factor inhibitors in rheumatic patients with past hepatitis B virus infection: an observational, controlled, long-term study. |
| 000656 (2018) |
Christopher P. Denton [Royaume-Uni] ; Voon H. Ong [Royaume-Uni] ; Shiwen Xu [Royaume-Uni] ; Haiyin Chen-Harris [États-Unis] ; Zora Modrusan [États-Unis] ; Robert Lafyatis [États-Unis] ; Dinesh Khanna [États-Unis] ; Angelika Jahreis [États-Unis] ; Jeffrey Siegel [États-Unis] ; Thierry Sornasse [États-Unis] | Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis. |
| 000658 (2018) |
Guanglei Fu [République populaire de Chine] ; Hua Wang [République populaire de Chine] ; Youli Cai [République populaire de Chine] ; Hui Zhao [République populaire de Chine] ; Wenjun Fu [République populaire de Chine] | Theaflavin alleviates inflammatory response and brain injury induced by cerebral hemorrhage via inhibiting the nuclear transcription factor kappa β-related pathway in rats. |
| 000759 (2018) |
Lluís Puig [Espagne] | Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab, Ixekizumab, and Others. |
| 000839 (2018) |
Charu Dwivedi [Inde] ; Ishan Pandey [Inde] ; Himanshu Pandey [Inde] ; Sandip Patil [Inde] ; Shanti Bhushan Mishra [Inde] ; Avinash C. Pandey [Inde] ; Paolo Zamboni [Italie] ; Pramod W. Ramteke [Inde] ; Ajay Vikram Singh [Allemagne] | In vivo diabetic wound healing with nanofibrous scaffolds modified with gentamicin and recombinant human epidermal growth factor. |
| 000863 (2018) |
Feifei Xu [République populaire de Chine] ; Shaoqing Yu [République populaire de Chine] ; Mali Qin [République populaire de Chine] ; Yong Mao [République populaire de Chine] ; Ling Jin [République populaire de Chine] ; Na Che [République populaire de Chine] ; Shuangxi Liu [République populaire de Chine] ; Rongming Ge [République populaire de Chine] | Hydrogen-Rich Saline Ameliorates Allergic Rhinitis by Reversing the Imbalance of Th1/Th2 and Up-Regulation of CD4+CD25+Foxp3+Regulatory T Cells, Interleukin-10, and Membrane-Bound Transforming Growth Factor-β in Guinea Pigs. |
| 000870 (2018) |
Yuqian Wang [République populaire de Chine] ; Yuxia Qin [République populaire de Chine] ; Tingwen Guo [République populaire de Chine] ; Chuanxi Tang [République populaire de Chine] ; Liyun Liu [République populaire de Chine] ; Dianshuai Gao [République populaire de Chine] | High Concentration of Glial Cell Line-Derived Neurotrophic Factor Protects Primary Astrocytes from Apoptosis. |
| 000912 (2018) |
Gholamhassan Haddadi [Iran] ; Akbar Abbaszadeh [Iran] ; Mohammad Amin Mosleh-Shirazi [Iran] ; Mohammad Ali Okhovat [Iran] ; Ashkan Salajeghe [Iran] ; Zhila Ghorbani [Iran] | Evaluation of the effect of hesperidin on vascular endothelial growth factor gene expression in rat skin animal models following cobalt-60 gamma irradiation. |
| 000921 (2018) |
Mariusz Papp [Pologne] ; Piotr Gruca [Pologne] ; Magdalena Lason-Tyburkiewicz [Pologne] ; Ewa Litwa [Pologne] ; Monika Niemczyk [Pologne] ; Katarzyna Tota-Glowczyk [Pologne] ; Agata Faron-Gorecka [Pologne] ; Maciej Kusmider [Pologne] ; Joanna Solich [Pologne] ; Marta Szlachta [Pologne] ; Paul Willner [Royaume-Uni] | Effects on brain-derived neurotrophic factor signalling of chronic mild stress, chronic risperidone and acute intracranial dopamine receptor challenges. |
| 000931 (2018) |
J W Baddley [États-Unis] ; F. Cantini [Italie] ; D. Goletti [Italie] ; J J G Mez-Reino [Espagne] ; E. Mylonakis [États-Unis] ; R. San-Juan [Espagne] ; M. Fernández-Ruiz [Espagne] ; J. Torre-Cisneros [Espagne] | ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents). |
